NCT01472705

Everolimus- Versus Biolimus-Eluting Stents in All-Comers

Long-Term Comparison of Everolimus-Eluting and Biolimus-Eluting Stents in All-Comer Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 814 (actual)
• Sponsor: University of Freiburg · Academic / Other
• Sex: All
• Age: 18 Years – 120 Years
• Healthy volunteers: Not accepted

Summary

This study sought to investigate safety and efficacy of biolimus-eluting stents (BES) with biodegradable polymer as compared with everolimus-eluting stents (EES) with durable polymer through 3 years of follow-up.

Detailed description

A group of 814 consecutive patients undergoing percutaneous coronary intervention (PCI) was enrolled between 2007 and 2010, of which 527 were treated with EES and 287 with BES implantation. Clinical outcome was compared in 200 pairs using propensity score matching. The primary endpoint was a composite of death, myocardial infarction (MI) and target vessel revascularisation (TVR) at two-year follow-up.

Conditions

• Coronary Artery Disease

Timeline

• Start date: 2010-11-01
• Primary completion: 2010-11-01
• Completion: 2011-11-01
• First posted: 2011-11-16
• Last updated: 2015-12-03

Locations

1 site across 1 country: Switzerland